ClinicalTrials.Veeva

Menu

Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results

General Electric (GE) logo

General Electric (GE)

Status

Completed

Conditions

Et Control Performance in Adult Population Surgery

Treatments

Device: Et Control Feature
Device: Conventional Fresh Gas

Study type

Interventional

Funder types

Industry

Identifiers

NCT02972892
123.07-2015-GES-0002

Details and patient eligibility

About

This is a clinical, single blind, randomized, prospective research study. The purpose of this pivotal study is to collect and analyze data on the investigational End tidal Control (Et Control) option feature. To demonstrate that End tidal Control (Et Control) performance is non-inferior to conventional anesthesia practice in an adult surgery population by comparing the performance of the Et Control Arm (investigational arm) to the Control Arm (fresh gas mode).

Full description

The purpose of this pivotal study is to demonstrate that End tidal Control performance is non-inferior to conventional anesthesia practice in an adult surgery population, and support a marketing application in the U.S. for clearance of this feature.

Enrollment

248 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female 18 years old or greater.

  2. Scheduled to undergo general inhaled anesthesia that can be safely exposed to 100% oxygen for up to 2 minutes during general anesthesia.

  3. Expected to have airway secured with laryngeal mask airway (LMA) or endotracheal tube.

  4. Undergoing a surgical procedure that is anticipated by the investigator to take greater than or equal to 1 hour (operative time measured from induction to cessation of general inhalation anesthetic).

  5. American Society of Anesthesiologists (ASA) status classification system I through III:

    1. ASA Physical Status 1 = a normal healthy patient
    2. ASA Physical Status 2 = a patient with mild systemic disease
    3. ASA Physical Status 3 = a patient with severe systemic disease
  6. Undergoing intravenous induction.

  7. Ability to provide written informed consent.

Exclusion criteria

  1. Have emergency medical condition requiring surgery.
  2. Are female subjects, who are pregnant or lactating.
  3. Any subject undergoing cardiac bypass surgery.
  4. Any subject undergoing open chest surgery.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

248 participants in 2 patient groups

Et Control
Experimental group
Description:
Subjects, meeting the American Society of Anesthesiologists status classification system 1-3, to undergo a surgical procedure with inhaled anesthesia using the investigational Et Control option intervention. For Subjects under the Et Control option, the investigator will use and initiate Et Control after the airway is secured and mechanical ventilation is initiated. Machine log data is collected when the investigator initiates the start of anesthesia case on the Aisys CS2. Adjustments to the anesthesia machine settings, discontinuation of use of the investigational Et Control option, and changes to treatment are based upon clinician judgment for the well being of the subject.
Treatment:
Device: Et Control Feature
Control Arm
Active Comparator group
Description:
Subjects, meeting the American Society of Anesthesiologists status classification system 1-3, to undergo a surgical procedure with inhaled anesthesia using conventional fresh gas intervention. For subjects under the conventional option, the investigator will use their conventional means to adjust the vaporizer and mixer, and monitor the patient gas concentrations with the legally marketed Aisys CS2 anesthesia machine without the investigational Et Control feature.
Treatment:
Device: Conventional Fresh Gas

Trial documents
1

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems